期刊文献+

英夫利西单抗治疗难治性贝赫切特综合征眼炎1例并文献复习 被引量:5

暂未订购
导出
摘要 贝赫切特综合征(Behcet syndrome;又称白塞病)为风湿免疫科常见病,是一种以血管炎症及多系统损害为特征的自身免疫性疾病。其主要临床表现为复发性口腔溃疡、生殖器溃疡、眼炎及皮肤损害,也可累及血管、关节、肺、肾、附睾等器官及神经系统、
作者 孙妍 任立敏
出处 《中华临床免疫和变态反应杂志》 2012年第4期321-324,共4页 Chinese Journal of Allergy & Clinical Immunology
  • 相关文献

参考文献21

二级参考文献226

  • 1张士发,王良明,张海涛,顾苏宁.白塞氏病125例临床分析[J].皮肤病与性病,1996,18(4):8-9. 被引量:3
  • 2谭兵,李瑜元,聂玉强.抗肿瘤坏死因子-α治疗的研究进展[J].国际内科学杂志,2007,34(3):143-147. 被引量:17
  • 3马百芳 张爱华 等.白塞病与EB病毒感染及干扰素治疗观察[J].中华皮肤科杂志,2001,34(1):63-63.
  • 4Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum, 1998, 27:197-217.
  • 5陈珠灏.实用内科学.11版.北京:人民卫生出版社,2002.
  • 6Evereklioglu C. Current concepts in the etiology and treatment of Behcet's disease. Surv Ophthalmol, 2005, 50: 297-350.
  • 7Tugal-Tutkun IS, Onal SNAL. Uveitis in Behcet's disease: an analysis of 880 patients. Am J Ophthahnol, 2004, 138: 373-380.
  • 8Kaklamani VG, Kaklamanis PG. Treatment of Behcet's disease: an update. Semin Arthritis Rheum, 2001, 30: 299-312.
  • 9Tsambaos D, Eichelberg D, Goos M. Behcet's syndrome: treatment with recombinant leukocyte alpha-interferon. Arch Dermatol Res, 1986, 278: 335-336.
  • 10Ergun T, Ince U, Eksioglu-Demiralp E, et al. HSP 60 expression in mucocutaneous lesions of Behcet's disease. J Am Acad Dermatol, 2001, 45: 904-909.

共引文献198

同被引文献32

  • 1张卓莉,彭劲民,侯小萌,董怡.1996例白塞病患者的临床荟萃分析[J].北京医学,2007,29(1):10-12. 被引量:68
  • 2刘相东,孙善会,肖东杰,牟国营,汪运山.白细胞介素-1受体拮抗剂基因型2/2与白塞病葡萄膜炎易感性的相关研究[J].山东大学学报(医学版),2007,45(5):467-469. 被引量:7
  • 3周国庆,赵岩,张美芬.依那西普治疗白塞病难治性色素膜炎一例并文献复习[J].中华内科杂志,2007,46(10):853-854. 被引量:3
  • 4Ahn JK,Yu HG,Chung H,et al.Intraocular cytokine environment inactive Behcet uveitis. American Journal of Ophthalmology . 2006
  • 5G Hatemi,A Silman,D Bang.EULAR recommendations for the management of Behcet’s disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases . 2008
  • 6Yamaoka J,Kabashima K,Kawanishi M,et al.Cytotoxicity of IFN-gamma and TNF-alpha for Vascular Endothelial Cell Is Mediated by Nitric Oxide. Biochemical and Biophysical Research Communications . 2002
  • 7Tracey D,Klareskog L,Sasso EH, et al.Tumor necrosis factor antagonist mechanisms of action:a comprehensive review. Pharmacology and Therapeutics . 2008
  • 8Sfikakis PP,Theodossiadis PG,Katsiari CG,et al.Effect of infliximab on sight-threatening panuveitis in Behcet’’s disease. The Lancet . 2001
  • 9Sfikakis PP,Markomichelakis N,Alpsoy E,et al.Anti-TNF therapy in the management of Behcet‘ s disease:review and basis for recommendations. Rheumatology . 2007
  • 10Perra D,Alba MA,Callejas JL,et al.Adalimumab for the treatmentof Behet’’s disease:experience in 19 patients. Rheumatology . 2012

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部